Orris

"ctDNA as a minimal residual disease biomarker after curative-intent pancreatic cancer resection" OR "ctDNA as a prognostic biomarker after curative-intent pancreatic cancer resection — systematic review and meta-analysis" would you recommend the below to be a good meta-analysis focused topic with good impact and feasibility

I'll evaluate this meta-analysis topic across the key dimensions of impact, feasibility, and originality. Let me search the current literature simultaneously.
Searching sources...
Searching PubMed

ctDNA minimal residual disease pancreatic cancer resection

Searching PubMed

circulating tumor DNA pancreatic cancer prognosis surgery meta-analysis

Searching the Web

ctDNA MRD pancreatic cancer resection systematic review meta-analysis 2024 2025

Now let me get the abstracts of the two most relevant existing meta-analyses to understand their scope and identify gaps.
Reading Article

PMID: 37852124

Reading Article

PMID: 37572593

Searching PubMed

ctDNA postoperative pancreatic cancer recurrence prognosis 2024 2025

Searching PubMed

ctDNA pancreatic ductal adenocarcinoma postoperative prognosis recurrence

Searching the Web

ctDNA MRD pancreatic cancer adjuvant therapy RCT 2025 2026 clinical trial

Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.
This is a shared conversation. Sign in to Orris to start your own chat.